GlassScriptPhysician profile
Mallory W Eaves
NPI 1952650954
$4,149.32
in general payments reported to CMS, 2019-2025
33 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $779 · 2022: $578 · 2023: $1,849 · 2024: $566 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,702 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,702.30 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $654.49 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $498.70 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Pfizer INC. | $388.24 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $320.38 | 2021-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $302.24 | 2021-2024 | Wainua, Farxiga, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.63 | 2021-2025 | Jardiance |
| Amgen INC. | $181.22 | 2021-2024 | Repatha |
| Merck Sharp & Dohme LLC | $175.25 | 2021-2025 | Verquvo, Winrevair |
| Baxter Healthcare | $140.68 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $135.57 | 2021-2023 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.81 | 2021-2023 | Lifevest |
| United Therapeutics Corporation | $100.21 | 2022-2023 | Tyvaso |
| Lexicon Pharmaceuticals, INC. | $93.00 | 2023-2024 | Inpefa |
| Boston Scientific Corporation | $88.76 | 2022-2023 | Watchman Flx, Wavewriter Alpha Prime 16 |
| Heartflow, INC. | $87.55 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $77.24 | 2022-2023 | Zio Xt Patch |
| Novo Nordisk INC | $63.83 | 2022-2023 | Wegovy, Ozempic |
| Alnylam Pharmaceuticals INC. | $62.65 | 2022-2023 | Amvuttra |
| Kiniksa Pharmaceuticals International, Plc | $46.70 | 2024 | Arcalyst |
| Astellas Pharma US INC | $35.46 | 2021 | |
| Inspire Medical Systems, INC. | $34.98 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $33.50 | 2021 | |
| Sanofi-Aventis U.S. LLC | $33.22 | 2023-2024 | |
| Vital Connect, INC | $32.56 | 2024 | Vitalpatch Rtm |
| Cvrx, INC. | $26.01 | 2024 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $22.21 | 2024 | Evkeeza |
| Bridgebio Pharma, INC. | $19.61 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $19.60 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $18.48 | 2025 | |
| Inari Medical, INC. | $18.02 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amarin Pharma, INC. | $15.36 | 2021 | |
| Philips North America LLC | $14.10 | 2023 | |
| Glaxosmithkline, LLC. | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Eaves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.